14-28767480-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP7BA1

This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Pro67= variant in FOXG1 is 0.055% in European (Non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The silent p.Pro67= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Pro67= variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BP7). LINK:https://erepo.genome.network/evrepo/ui/classification/CA290947/MONDO:0100040/016

Frequency

Genomes: 𝑓 0.00028 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00070 ( 0 hom. )

Consequence

FOXG1
NM_005249.5 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:7

Conservation

PhyloP100: 1.06

Publications

1 publications found
Variant links:
Genes affected
FOXG1 (HGNC:3811): (forkhead box G1) This locus encodes a member of the fork-head transcription factor family. The encoded protein, which functions as a transcriptional repressor, is highly expressed in neural tissues during brain development. Mutations at this locus have been associated with Rett syndrome and a diverse spectrum of neurodevelopmental disorders defined as part of the FOXG1 syndrome. This gene is disregulated in many types of cancer and is the target of multiple microRNAs that regulate the proliferation of tumor cells. [provided by RefSeq, Jul 2020]
LINC01551 (HGNC:19828): (long intergenic non-protein coding RNA 1551)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP7
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXG1NM_005249.5 linkc.201G>T p.Pro67Pro synonymous_variant Exon 1 of 1 ENST00000313071.7 NP_005240.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXG1ENST00000313071.7 linkc.201G>T p.Pro67Pro synonymous_variant Exon 1 of 1 6 NM_005249.5 ENSP00000339004.3
FOXG1ENST00000706482.1 linkc.201G>T p.Pro67Pro synonymous_variant Exon 2 of 2 ENSP00000516406.1
LINC01551ENST00000675861.1 linkn.374+1467G>T intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.000285
AC:
41
AN:
144068
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000999
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000121
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000537
Gnomad OTH
AF:
0.000511
GnomAD2 exomes
AF:
0.000274
AC:
20
AN:
73010
AF XY:
0.000166
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000150
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000770
Gnomad NFE exome
AF:
0.000520
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000703
AC:
696
AN:
990522
Hom.:
0
Cov.:
18
AF XY:
0.000685
AC XY:
328
AN XY:
479048
show subpopulations
African (AFR)
AF:
0.000349
AC:
7
AN:
20084
American (AMR)
AF:
0.000108
AC:
2
AN:
18598
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13150
East Asian (EAS)
AF:
0.00
AC:
0
AN:
13144
South Asian (SAS)
AF:
0.00
AC:
0
AN:
37700
European-Finnish (FIN)
AF:
0.000567
AC:
9
AN:
15862
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2374
European-Non Finnish (NFE)
AF:
0.000787
AC:
657
AN:
834402
Other (OTH)
AF:
0.000596
AC:
21
AN:
35208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
32
64
96
128
160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000284
AC:
41
AN:
144166
Hom.:
0
Cov.:
31
AF XY:
0.000342
AC XY:
24
AN XY:
70130
show subpopulations
African (AFR)
AF:
0.0000997
AC:
4
AN:
40132
American (AMR)
AF:
0.00
AC:
0
AN:
14572
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3318
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4958
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4654
European-Finnish (FIN)
AF:
0.000121
AC:
1
AN:
8258
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
272
European-Non Finnish (NFE)
AF:
0.000537
AC:
35
AN:
65124
Other (OTH)
AF:
0.000505
AC:
1
AN:
1980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000278
Hom.:
0
Bravo
AF:
0.000283

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FOXG1: BP4, BP7

Jun 26, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Jun 22, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Aug 23, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

FOXG1 disorder Benign:1
Mar 26, 2021
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The allele frequency of the p.Pro67= variant in FOXG1 is 0.055% in European (Non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The silent p.Pro67= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Pro67= variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BP7).

FOXG1-related disorder Benign:1
Apr 04, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Rett syndrome, congenital variant Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
11
DANN
Benign
0.95
PhyloP100
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587780944; hg19: chr14-29236686; API